Becker's Hospital Review

FDA: Nonmedical wearable health data won’t face oversight

FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for ...
The American Bazaar

FDA moves to ease oversight of wearable health and wellness devices

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...
The American Journal of Managed Care

Global Gaps in Drug Access After FDA Approval: Insights From New Study and Ethics Guidelines

Lower-income countries rarely gain timely access to FDA-approved drugs tested in their populations, highlighting major global and ethical disparities. Physical access was defined as where a tested ...
Los Angeles Times

Letters to the Editor: What makes drug research so expensive, even before the FDA approval process?

This is read by an automated voice. Please report any issues or inconsistencies here. A rare-disease patient questions what drives research costs behind $41,000-per-month medication, even before FDA ...
KTLA

Exclusive: Safe, Direct-to-Brain Autologous Stem Cell Therapy Shows Promise in Alzheimer’s

(FDA Access Data U.S. Food and Drug Administration FDA Access Data.) There have been no such adverse events with the RBI cells. • Leqembi and Kisunla do not improve cognition, they only slow the ...